Home539871 • BOM
add
Thyrocare Technologies Ltd
Previous close
₹1,338.30
Day range
₹1,273.15 - ₹1,330.00
Year range
₹658.00 - ₹1,356.95
Market cap
69.54B INR
Avg Volume
8.48K
P/E ratio
76.20
Dividend yield
1.60%
Primary exchange
NSE
Financials
Income Statement
Revenue
Net income
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.93B | 23.02% |
Operating expense | 580.40M | 12.81% |
Net income | 389.30M | 61.07% |
Net profit margin | 20.17 | 30.97% |
Earnings per share | 7.33 | 62.53% |
EBITDA | 579.35M | 34.63% |
Effective tax rate | 24.15% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.55B | -13.85% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 5.47B | — |
Shares outstanding | 52.97M | — |
Price to book | 12.97 | — |
Return on assets | — | — |
Return on capital | 20.27% | — |
Cash Flow
Net change in cash
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 389.30M | 61.07% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Founded
1996
Headquarters
Website
Employees
1,822
